Jules A. Musing's most recent trade in TherapeuticsMD Inc was a trade of 5,000 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 29, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TherapeuticsMD Inc | Jules A. Musing | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Jules A. Musing | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 0 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Jules A. Musing | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 4,022 (0%) | 0% | - | Common Stock | |
TherapeuticsMD Inc | Jules A. Musing | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 101,864 (0%) | 0% | - | Common Stock | |
TherapeuticsMD Inc | Jules A. Musing | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 0 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Jules A. Musing | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 99,174 | 99,174 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Jules A. Musing | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 96,864 | 96,864 | - | - | Restricted Stock Units |